
Aeterna Zentaris AEZS
Geschäftsbericht 2024
hinzugefügt 21.02.2026
Aeterna Zentaris DPO 2011-2026 | AEZS
DPO Jährlich Aeterna Zentaris
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | 34.4 K | 90.8 | 107 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 34.4 K | 90.8 | 11.5 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agenus
AGEN
|
6.01 K | $ 3.27 | -1.8 % | $ 1.17 M | ||
|
Agios Pharmaceuticals
AGIO
|
1.01 K | $ 29.33 | -2.98 % | $ 1.7 B | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Akebia Therapeutics
AKBA
|
168 | $ 1.26 | -3.44 % | $ 324 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Alector
ALEC
|
13.8 | $ 2.26 | -7.2 % | $ 233 M | ||
|
Alkermes plc
ALKS
|
143 | $ 29.32 | -2.61 % | $ 4.83 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
55 | $ 330.95 | -0.59 % | $ 43.4 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Amgen
AMGN
|
64.8 | $ 387.85 | 0.03 % | $ 209 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 20.22 | -0.05 % | $ 945 M | ||
|
Amarin Corporation plc
AMRN
|
190 | $ 13.62 | -1.3 % | $ 5.55 B | ||
|
AIM ImmunoTech
AIM
|
0.173 | $ 0.92 | 5.25 % | $ 44.2 M | ||
|
Anika Therapeutics
ANIK
|
54.4 | $ 14.44 | 0.53 % | $ 212 M | ||
|
ANI Pharmaceuticals
ANIP
|
60.1 | $ 75.31 | 1.91 % | $ 1.45 B | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.78 | -0.67 % | $ 4.25 M | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
Aptevo Therapeutics
APVO
|
239 | $ 7.28 | -0.55 % | $ 2.01 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Aquestive Therapeutics
AQST
|
196 | $ 3.99 | -0.15 % | $ 346 M | ||
|
Ardelyx
ARDX
|
163 | $ 6.32 | -3.54 % | $ 1.52 B |